August 08, 2005 10:30 ET

AtheroGenics, Inc. [AGIX] President & CEO to Ring The NASDAQ Stock Market Opening Bell

Company Celebrates Anniversary

-- (MARKET WIRE) -- August 8, 2005 --


Russell M. Medford, M.D., Ph.D., President & CEO of AtheroGenics, Inc. (NASDAQ: AGIX), will preside over the opening bell to celebrate AtheroGenics' 5-year anniversary on the NASDAQ. AtheroGenics is focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. AtheroGenics' lead compound, AGI-1067, is being evaluated in a pivotal Phase III clinical trial as an oral therapy for the treatment of atherosclerosis.


NASDAQ MarketSite -- 4 Times Square -- 43rd & Broadway -- Broadcast Studio


Tuesday, August 9th, 2005 at 9:30 a.m. EDT

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA-5 C-band/transponder 14. The downlink frequency is 3980 horizontal; audio: 6.2/6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.


To obtain a hi-resolution photograph of the Market Open, please go to and click on the market open of your choice.

Contact Information

  • Contact:
    Donna Glasky
    Manager Corporate Communications
    (678) 336-2517
    Email Contact

    NASDAQ MarketSite:
    Stephanie Lowenthal